HUTCHMED (China)

HCMNasdaq Hong Kong Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.183 B

$12.51 +5.75%

Close of 7 Aug 2026

Revenue

$548.5M

#1869 by revenue

Earnings

$456.9M

#651 by earnings

Shares outstanding

872,327,620

Latest filing cover page

P/E ratio

4.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#106BiohavenBHVN$2.21B
#107Braveheart BioBRVE$2.20B
#108HUTCHMED (China)HCM$2.18B
#109Rapport TherapeuticsRAPP$2.18B
#110Stoke TherapeuticsSTOK$2.11B

Where these numbers come from

Share counts and financials for HUTCHMED (China) are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.